Advances in the use of Radiomics and Pathomics for predicting the efficacy of neoadjuvant therapy in tumors

Neoadjuvant therapy is widely used for treating malignant tumors, but its efficacy varies among patients. Currently, tools or biomarkers for early and accurate evaluation of the efficacy of neoadjuvant therapy are lacking. The advent of radiomics and pathomics offers new avenues for refining neoadju...

Full description

Bibliographic Details

Published in:	Translational Oncology
Main Authors:	Jiayi Wang, Jiahui Dai, Yangxi Cheng, Xirui Wang, Rui Deng, Huiyong Zhu
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Subjects:	Radiomics Pathomics Multi-omics Neoadjuvant therapy Efficacy
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523325001664